• Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.

  • Nov 27 2024
  • Duración: 35 m
  • Podcast

Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.

  • Resumen

  • Brandy Hernandez, PharmD shares nuances on the use of uridine triacetate and glucarpidase in chemotherapy toxicity management

    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.

    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on X @MayoMedE

    Más Menos

Lo que los oyentes dicen sobre Antidotes or Ambiguity? Understanding the use of uridine triacetate and glucarpidase in chemotherapy toxicity.

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.